WHO WE ARE
Every patient matters
Our pipeline contains novel therapies designed to address debilitating CNS mediated conditions in order to improve quality of life and patient outcomes.
We partner with patients, families and caregivers, and healthcare professionals to provide a comprehensive approach beyond treating symptoms to ensure that patients’ experiences, perspectives, needs, and priorities are meaningfully incorporated into our work.
A History of Success
Our leadership team has extensive experience with global biotech and pharmaceutical companies and a proven track record of developing and commercializing treatments for central nervous system (CNS) disorders.
The Noema Team
Ilise Lombardo, MD
Chief Executive Officer
Volker Knappertz, MD
Executive Vice President of Research & Development
Rob Lasser, MD
Chief Medical Officer
Sally Nixon
Head of Operations
Amine Tahiri PharmD, MBA
VP Clinical Development, Adult Programs
Michel David
VP CMC & Clinical Supply
